Osteo Signal is an AI-powered software that analyzes chest X-rays to screen patients at risk for osteoporosis.
Approved by the Ministry of Food and Drug Safety (MFDS) and designated as a New Medical Technology with Deferred Evaluation, the product has been recognized for its technological excellence and innovation, allowing it to be billed to patients as a non-reimbursable (out-of-pocket) service.
It is easy to install and use, seamlessly integrating with hospital PACS networks to automatically screen for suspected osteoporosis patients without requiring any additional manual steps.
This enables healthcare professionals to recommend bone density tests (DXA) sooner and intervene earlier, providing patients with faster diagnosis and timely treatment opportunities.